data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
BioLine Rx
(NASDAQ:BLRX)
$1.29
-0.01[-0.77%]
At close: Jul 1
$1.25
-0.0400[-3.10%]
PreMarket: 7:38PM EDT
Day High/Low- - -
52 Week High/Low1.01 - 3.62
Open / Close- / -
Float / Outstanding- / 47.9M
Vol / Avg.0K / 171.6K
Mkt Cap61.8M
P/E-
50d Avg. Price1.33
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float-

BioLine Rx (NASDAQ:BLRX), Quotes and News Summary

BioLine Rx (NASDAQ: BLRX)

Day High/Low- - -
52 Week High/Low1.01 - 3.62
Open / Close- / -
Float / Outstanding- / 47.9M
Vol / Avg.0K / 171.6K
Mkt Cap61.8M
P/E-
50d Avg. Price1.33
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float-
Benzinga - 5 days ago
Benzinga - 6 days ago
Benzinga - May 12, 2022, 2:09PM
Benzinga - May 11, 2022, 7:14AM
Benzinga - Mar 17, 2022, 12:55PM
Benzinga - Mar 16, 2022, 7:02AM
Benzinga - Mar 3, 2022, 7:16AM
Benzinga - Jan 31, 2022, 9:20AM
Benzinga - Jan 24, 2022, 7:03AM
Benzinga - Jan 18, 2022, 7:04AM
Benzinga - Dec 15, 2021, 7:15AM
Benzinga - Nov 18, 2021, 7:30AM
Benzinga - Oct 13, 2021, 8:31AM
Benzinga - Aug 18, 2021, 7:07AM
load more
Sector: Health Care.Industry: Biotechnology
BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the treatment of skin lesions.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-17
REV
Q1 2022Est.ActualSurprise
EPS-0.150-0.100 0.0500
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

BioLine Rx Questions & Answers

Q
How do I buy BioLine Rx (BLRX) stock?
A

You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are BioLine Rx's (BLRX) competitors?
Q
What is the target price for BioLine Rx (BLRX) stock?
A

The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by HC Wainwright & Co. on Tuesday, February 23, 2021. The analyst firm set a price target for 19.00 expecting BLRX to rise to within 12 months (a possible 1372.87% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for BioLine Rx (BLRX)?
A

The stock price for BioLine Rx (NASDAQ: BLRX) is $1.29 last updated July 1, 2022, 8:00 PM UTC.

Q
Does BioLine Rx (BLRX) pay a dividend?
A

There are no upcoming dividends for BioLine Rx.

Q
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
A

BioLine Rx’s Q2 earnings are confirmed for Wednesday, August 17, 2022.

Q
Is BioLine Rx (BLRX) going to split?
A

There is no upcoming split for BioLine Rx.

Q
What sector and industry does BioLine Rx (BLRX) operate in?
A

BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.